Conversely, knockdown of HIF1A decreases NET release in human neutrophils139 and inhibition of HIF1A with dihydromyricetin reduces NET release and inflammation in mouse IBD models.140. This evidence concerns the gene HIF1A and inflammatory bowel disease.